TWD 36.6
(0.97%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 267.27 Million TWD | -3.95% |
2022 | 278.25 Million TWD | -5.78% |
2021 | 295.33 Million TWD | -2.41% |
2020 | 302.63 Million TWD | 6.1% |
2019 | 285.24 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 62.4 Million TWD | -9.58% |
2024 Q2 | 55.19 Million TWD | -11.55% |
2023 Q4 | 69.01 Million TWD | 5.4% |
2023 FY | 267.27 Million TWD | -3.95% |
2023 Q3 | 65.47 Million TWD | -0.19% |
2023 Q2 | 65.59 Million TWD | -2.38% |
2023 Q1 | 67.19 Million TWD | -1.74% |
2022 FY | 278.25 Million TWD | -5.78% |
2022 Q4 | 68.38 Million TWD | 0.0% |
2021 FY | 295.33 Million TWD | -2.41% |
2020 FY | 302.63 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Allied Biotech Corporation | 157.72 Million TWD | -69.456% |
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -101.282% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | 19.847% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 86.019% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 82.177% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 87.553% |
Center Laboratories, Inc. | 697.35 Million TWD | 61.673% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 42.971% |
InnoPharmax Inc. | 82.29 Million TWD | -224.772% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | -9.255% |
Excelsior Biopharma Inc. | 388.05 Million TWD | 31.125% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 53.537% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 76.17% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | 33.039% |
UniPharma Co., Ltd. | 78.32 Million TWD | -241.255% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 32.665% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -219.152% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | -76.422% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -45047.635% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -175.591% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | 20.518% |